The Comprehensive Cancer Center Zurich (CCCZ) is an oncology center of excellence of the University Hospital Zurich (USZ) and the University of Zurich (UZH), including the Balgrist University Hospital and the University Children's Hospital Zurich.
The Comprehensive Cancer Center Zurich unites innovative cancer research and cancer medicine.
As an interdisciplinary research platform, CCCZ facilitates cutting edge research on the molecular and cellular mechanisms of cancer, the establishment of novel technologies and the development of innovative clinical trials.
Dedicated CCCZ research areas have been established for Tumor Immunology, (Epi)Genetics & Genomics, Oncogenic Signaling and Imaging, Technology Development and Digitalization. In these areas, scientists and physicians from around 60 research groups and clinical departments work closely together to facilitate the translation of scientific discoveries into clinical application.
The overall aim is to develop novel diagnostic and therapeutic concepts towards precision oncology.
The Comprehensive Cancer Center Zurich develops and offers innovative clinical trials for the treatment of cancer.
The Comprehensive Cancer Center Zurich integrates and supports cancer research activities of the UZH, USZ, Children`s University Hospital and the Balgrist University Hospital.
Connecting basic research with oncological patient care
Learn more about recent publications from CCCZ members.
The Fellow & Funding Program of the Comprehensive Cancer Center Zurich (2018-2022) supports innovative, interdisciplinary cancer research projects.
Call for projects 2022-2025.
under the umbrella of the Comprehensive Cancer Center Zurich.
Are you looking for funding opportunities for your next research project, a travel grant or a PhD fellowship? Visit *Research Professional.
The Comprehensive Cancer Center Zurich aims to recruit and train the next generation of talented scientists, physicians and professionals in oncology.